Nasopharynx and larynx cancer with throat and larynx tissue test array |
|||
T161 | TissueArray | each | EUR 48 |
Description: Nasopharynx and larynx cancer with throat and larynx tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores |
Blood Elisa Laboratories manufactures the blood screening test with elisa reagents distributed by Genprice. The Blood Screening Test With Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact blood elisa. Other Blood products are available in stock. Specificity: Blood Category: Screening Group: Test With
Human True insulin ELISA kit |
||
BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
||
BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat True insulin ELISA kit |
||
BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Rat True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat True insulin ELISA kit |
||
BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Rat True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat True insulin ELISA kit |
||
BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Rat True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat True insulin ELISA kit |
||
BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Goat True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat True insulin ELISA kit |
||
BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Goat True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Lectin Screening Kit 2 - AP |
|||
21511421-1 | Bio-WORLD | - | EUR 327.62 |
Lectin Screening Kit 3 - AP |
|||
21511423-1 | Bio-WORLD | - | EUR 327.62 |
Lectin Screening Kit 1 - AP |
|||
22110038-1 | Bio-WORLD | - | EUR 252.62 |
DPP4 Inhibitor Screening Kit |
|||
55R-1527 | Fitzgerald | 100 assays | EUR 1051.2 |
Description: Screening Kit for detection of DPP4 Inhibitor in the research laboratory |
BACTERIA SCREENING MEDIUM 523 |
|||
B129 | PhytoTechnology Laboratories | 100G | EUR 70.55 |
Lectin Screening Kit 1 - Cy3 |
|||
21511012-1 | Bio-WORLD | - | EUR 442.07 |
Lectin Screening Kit 1 - Cy5 |
|||
21511013-1 | Bio-WORLD | - | EUR 343.16 |
Lectin Screening Kit 2 - Cy3 |
|||
21511019-1 | Bio-WORLD | - | EUR 442.07 |
Lectin Screening Kit 2 - Cy5 |
|||
21511020-1 | Bio-WORLD | - | EUR 343.16 |
Lectin Screening Kit 3 - Cy3 |
|||
21511129-1 | Bio-WORLD | - | EUR 442.07 |
Lectin Screening Kit 3 - Cy5 |
|||
21511322-1 | Bio-WORLD | - | EUR 343.16 |
Lectin Screening Kit 1 - HRP |
|||
21511418-1 | Bio-WORLD | - | EUR 326.33 |
Lectin Screening Kit 2 - HRP |
|||
21511420-1 | Bio-WORLD | - | EUR 311.33 |
Lectin Screening Kit 3 - HRP |
|||
21511422-1 | Bio-WORLD | - | EUR 311.33 |
PD-1 [Biotinylated] : PD-L1 Inhibitor Screening ELISA Kit |
|||
EP-101 | ACROBIOSYSTEMS | 96tests | EUR 652.7 |
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists. |
PD-1 [Biotinylated] : PD-L2 Inhibitor Screening ELISA Kit |
|||
EP-120 | ACROBIOSYSTEMS | 96tests | EUR 706.2 |
Description: PD-L2, also known as CD273 or B7-DC, is a member of the B7 family protein with PD-L1, and it is the second important ligand that can bind pD-1 after PD-L1. The human PD-L2(B7-H2, CD273) gene is also located on chromosome 9p24, encoding type I transmembrane protein with 247 amino acids. The homology of PD-L1 and PD-L2 was 40%. The affinity between PD-L2 and PD-1 is 2-6 times that of PD-L1. Compared with PD-L1, the expression of PD-L2 is relatively limited, and pD-L2 is induced to express on the surface of dendritic cells, macrophages, bone marrow derived mast cells and other cells. |
PD-1 : PD-L1 [Biotinylated] Inhibitor Screening ELISA Kit |
|||
EP-130 | ACROBIOSYSTEMS | 96tests | EUR 652.7 |
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists. |